Life Science Nation Newsletter  | September 15,  2016  |  Issue 179

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Sept. 8  - Sept. 14)
Invests in Healthcare IT Opportunities
Seeks Connected and Wearable Devices in Cardio, Genetics and Mental Health
Seeks Diagnostic, Biotech and Device Deals Worldwide
Invests in Aesthetics and Anti-Aging Tech
In This Issue
News
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Videos
RESI Landing on MaRS

RESI on MaRS Investors Panel

By Shaoyu Chang, MD, MPH, Senior Research Manager & Asia Business Development Liaison, LSN

On September 13, a record number of 700 entrepreneurs and investors entered the exhibition hall at Westin Copley Place, Boston, MA. They were greeted by 30 Innovation Challenge finalists-companies from the biopharma, biotech, medical device, diagnostics, and digital health sectors. The teams were screened and selected from over a hundred applicants; all were very strong competitors, but only one winner could emerge from the all-day exhibition-style contest!

First Place: BioMedomics, Inc. (Durham, NC, USA)
Frank Wang, PhD, CEO, BioMedomics

Second Place: Epitel (Salt Lake City, UT, USA)
Michael Quigley, VP of Market Research, Life Science Nation
Jean Marie Wheeler, Regulatory Science and Engineering, Epitel
Mark Lehmkuhle, CEO,CTO, Epitel

Third Place: Novoron Bioscience, Inc. (San Diego, CA, USA)
Michael Quigley, VP of Market Research, Life Science Nation
Dr. Travis Stiles, CEO & President, Novoron Bioscience

Thank you to all who competed in RESI X Innovation Challenge, and to all the RESI attendees who took part by investing their votes in their favorite competing companies. If you'd like to be part of the RESI San Francisco Innovation Challenge, apply now.

By Nono Hu, Director of Marketing, LSN

In recent weeks we've covered how to make a global target list of potential investors, and the basic techniques of phone canvassing and email outreach required to initiate dialogue. This week, LSN takes a look under the hood of the investment process. How do you turn that initial spark of interest into an allocation check?

This chapter explains how you can move the process forward through the pipeline and describes the people you'll have to work with in order to make the allocation happen-from the initial gatekeepers to the final decision-makers. We look at how to make a good first impression and how to run a productive meeting with an investor, and explore what will happen during the due diligence process. If you're preparing to meet with a potential investor in the near future, this chapter will be invaluable.